Previous 10 | Next 10 |
Search all stock news releases related news releases and press releases from US and Canada Markets.
Q1 Total Revenue of $173.4 million, up 20% year-over-year Q1 Subscription Revenue of $157.7 million, up 24% year-over-year First ever GAAP net income reported as a publicly traded company Continued growth and operational improvements generate net ca...
Datadog Launches Workflow Automation for Faster Remediation of Application Issues PR Newswire Workflow Automation provides customers with out-of-the-box actions and pre-built templates to proactively remediate issues and avoid service disruptions or impact to end users ...
PagerDuty, Inc. (NYSE:PD), a global leader in digital operations management, today announced that members of its management team will present at William Blair's 43rd Annual Growth Stock Conference on Tuesday, June 6th, at 11:40am ET. And, at Baird's 2023 Global Consumer, Technology & Services...
CRO Steve Pace to retire; Dan Zugelder appointed as next CRO of Dynatrace Dynatrace (NYSE: DT), the leader in unified observability and security, today announced that its Chief Revenue Officer (CRO), Steve Pace, plans to retire from the company and that Dan Zugelder will be appointe...
Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust (“REIT”) focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. G...
ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC showed a 50% (3/6) response rate (2 cPR, 1 uPR), reinforcing ERAS-007 as a potential best-in-class ERK inhibitor Ongoing clinical programs for naporafenib, ERAS-007, ERAS-601, and ERAS-801 in ...
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced that 12-month data from the U.S.-based Pha...
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, today announced that Jean-François Formela, M.D. is ret...
THE WOODLANDS, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the closing of Lexicon’s previously announced public offering and concurrent private placement of shares of its common stock. The closing included the issuance and sale of a...
Highlights of the first quarter include: Revenue of $244.4 million, an increase of 19% compared to $205.7 million in Q1 FY23. Net income of $4.1 million, compared to net loss of $13.6 million in Q1 FY23, with non-GAAP net income of $42.8 million, an ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-1.89%Change Percent:
Loop Media Inc Company Name:
LPTV Stock Symbol:
OTCMKTS Market: